1. Home
  2. FLNT vs IXHL Comparison

FLNT vs IXHL Comparison

Compare FLNT & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fluent Inc.

FLNT

Fluent Inc.

HOLD

Current Price

$2.54

Market Cap

52.5M

ML Signal

HOLD

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$0.41

Market Cap

49.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLNT
IXHL
Founded
2001
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
Advertising
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
52.5M
49.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FLNT
IXHL
Price
$2.54
$0.41
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$2.50
N/A
AVG Volume (30 Days)
51.8K
26.4M
Earning Date
11-13-2025
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$212,352,000.00
$12,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$11.56
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.50
$0.08
52 Week High
$3.12
$2.25

Technical Indicators

Market Signals
Indicator
FLNT
IXHL
Relative Strength Index (RSI) 61.61 51.98
Support Level $1.94 $0.40
Resistance Level $2.20 $0.47
Average True Range (ATR) 0.23 0.04
MACD 0.06 -0.00
Stochastic Oscillator 67.39 38.26

Price Performance

Historical Comparison
FLNT
IXHL

About FLNT Fluent Inc.

Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: